Table 3.
Cases/Controls | Full OXPHOS | Complex I | Complex IV | ||||
---|---|---|---|---|---|---|---|
OR (95% CI) |
p | OR (95% CI) |
p | OR (95% CI) |
p | ||
All ischemic stroke |
1048/1384 | 1.17 (1.03- 1.33) |
0.008 | 1.06 (1.00-1.12) |
0.050 | 1.05 (0.99-1.12) |
0.075 |
SV only | 197/1384 | 1.16 (1.04- 1.29) |
0.007 | 1.13 (1.01-1.26) |
0.027 | 1.14 (1.02-1.27) |
0.018 |
| |||||||
All ICH | 928/548 | --- | --- | --- | --- | 1.08 (1.01-1.17) |
0.039 |
Deep only |
430/548 | --- | --- | --- | --- | 1.14 (1.03-1.25) |
0.008 |
Genetic score analysis results in the ISGS/SWISS validation cohort and ISGC ICH extension cohort, performed only on gene sets and subgroups with significant p-values in gene set enrichment analysis. Odds ratios represent risk per unit increase in risk score quintile.
CI = confidence interval, OR = odds ratio, OXPHOS = all structural proteins directly contributing to oxidative phosphorylation complex function, SV = small vessel stroke, --- = analysis not performed.
Nominal p-values are reported for association with ischemic stroke and ICH in the validation and extension cohorts.